Topography of cortical thinning in the Lewy body diseases.
Topography of cortical thinning in the Lewy body diseases.
复制标题
路易体疾病中皮质变薄的地形。
DOI:
10.1016/j.nicl.2020.102196
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Gomperts,StephenN
中科院分区:
文献类型:
--
作者:
Ye,Rong;Touroutoglou,Alexandra;Brickhouse,Michael;Katz,Samantha;Growdon,JohnH;Johnson,KeithA;Dickerson,BradfordC;Gomperts,StephenN
ObjectiveRegional cortical thinning in dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD) may underlie some aspect of their clinical impairments; cortical atrophy likely reflects extensive Lewy body pathology with alpha-synuclein deposits, as well as associated Alzheimer's disease co-pathologies, when present. Here we investigated the topographic distribution of cortical thinning in these Lewy body diseases compared to cognitively normal PD and healthy non-PD control subjects, explored the association of regional thinning with clinical features and evaluated the impact of amyloid deposition.MethodsTwenty-one participants with dementia with Lewy bodies (DLB), 16 with Parkinson disease (PD) - associated cognitive impairment (PD-MCI and PDD), and 24 cognitively normal participants with PD underwent MRI, PiB PET, and clinical evaluation. Cortical thickness across the brain and in regions of interest (ROIs) was compared across diagnostic groups and across subgroups stratified by amyloid status, and was related to clinical and cognitive measures.ResultsDLB and PD-impaired groups shared a similar distribution of cortical thinning that included regions characteristic of AD, as well as the fusiform, precentral, and paracentral gyri. Elevated PiB retention in DLB and PD-impaired but not in PD-normal participants was associated with more extensive and severe cortical thinning, in an overlapping topography that selectively affected the medial temporal lobe in DLB participants. In DLB, greater thinning in AD signature and fusiform regions was associated with greater cognitive impairment.ConclusionsThe pattern of cortical thinning is similar in DLB and PD-associated cognitive impairment, overlapping with and extending beyond AD signature regions to involve fusiform, precentral, and paracentral regions. Cortical thinning in AD signature and fusiform regions in these diseases reflects cognitive impairment and is markedly accentuated by amyloid co-pathology. Further work will be required to determine whether the distinct topography of cortical thinning in DLB and PD-associated cognitive impairment might have value as a diagnostic and/ or outcome biomarker in clinical trials.
登录
查看更多内容
DOI:
--
发表时间:
1987
期刊:
影响因子:
--
作者:
S. P. Brimmer;W. Fawcett;K. Kulhavy
通讯作者:
K. Kulhavy
影响因子:
7.4
作者:
M. Sepaniak;R. Cole
通讯作者:
R. Cole
DOI:
10.1016/s0021-9673(01)96347-2
发表时间:
1983-01-01
期刊:
JOURNAL OF CHROMATOGRAPHY
影响因子:
--
作者:
HJERTEN, S
通讯作者:
HJERTEN, S
DOI:
10.1002/chin.198012082
发表时间:
1979-12
期刊:
ChemInform
影响因子:
--
作者:
G. McIntire;H. N. Blount
通讯作者:
G. McIntire;H. N. Blount
影响因子:
1.3
作者:
Burton De;M. Sepaniak;M. P. Maskarinec
通讯作者:
M. P. Maskarinec